Skip to main content

Table 2

From: Description of the localized scleroderma subgroup of CARRAnet

  Oral methotrexate Subcutaneous methotrexate Mycophenolate mofetil Intravenous corticosteroids Longterm daily corticosteroids
Subjects (%) 21/42 (50%) 15/42 (36%) 15/42 (36%) 28-36 (78%) 17/35 (49%)
Current use 12 4 4 5 5
Past use 9 11 11 23 12